SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-028843
Filing Date
2018-05-15
Accepted
2018-05-15 16:01:51
Documents
5
Period of Report
2018-06-13
Effectiveness Date
2018-05-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv494039_def14a.htm DEF 14A 476838
2 GRAPHIC tv494039_img1.jpg GRAPHIC 9368
3 GRAPHIC tv494039_img2.jpg GRAPHIC 8974
4 GRAPHIC proxy_001.jpg GRAPHIC 287467
5 GRAPHIC proxy_002.jpg GRAPHIC 225488
  Complete submission text file 0001144204-18-028843.txt   1210299
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15070 | Film No.: 18836190
SIC: 2834 Pharmaceutical Preparations